Search results
Results from the WOW.Com Content Network
The Medicines Technologies Catapult was established in December 2015, [2] funded by a £10m grant from Innovate UK and based at the Alderley Park science park in Cheshire. [3] On 1 March 2016 its name changed to the Medicines Discovery Catapult. [2] Further funding of approximately £10m per year was secured from Innovate UK for the years 2018 ...
In 2021 part of the radiochemistry facility began to be used by the Medicines Discovery Catapult. [12] [13] External links. University of Manchester Imaging Facilities;
Catapult centres are a network of nine organisations set up by Innovate UK in the United Kingdom, to promote research and development (R&D) and to exploit market opportunities. [ 1 ] [ 2 ] [ 3 ] Catapult centres promote R&D and innovation through business-led collaboration between scientists, academics, engineers, entrepreneurs, industry ...
As of 2017, over 150 companies are based at Alderley Park, including Royal London, the Medicines Discovery Catapult [12] and the AMR Centre. [13] See also.
Alderley Park, Cheshire – led by Medicines Discovery Catapult; Cambridge – AstraZeneca, GlaxoSmithKline and Cambridge University; Glasgow – Glasgow University, supported by the Scottish Government; Milton Keynes – UK Biocentre, part of the National Institute for Health Research and with Alan McNally as the infectious diseases lead
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
A national study discovered that teens in the United States consumed significantly less alcohol and drugs in 2024 compared to past years. Teen alcohol use has steadily decreased from 2000 to 2024 ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more